Date Filed | Type | Description |
08/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/07/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/04/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/05/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
01/26/2022 |
SC 13G/A
| Granite Point Capital Management, L.P. reports a 0% stake in Neuronetics, Inc. |
11/10/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/11/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/05/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/05/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
10/07/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
09/18/2020 |
SC 13G
| Granite Point Capital Management, L.P. reports a 6.9% stake in Neuronetics, Inc. |
08/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/10/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
01/27/2020 |
SC 13G/A
| Granite Point Capital Management, L.P. reports a 3.1% stake in Marinus Pharmaceuticals, Inc. |
10/29/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/29/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/05/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
01/23/2019 |
SC 13G/A
| Granite Point Capital Management, L.P. reports a 8.1% stake in Marinus Pharmaceuticals, Inc. |
11/09/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/08/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
01/11/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/13/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/10/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/18/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|